Simulations Plus Overview
- Year Founded
-
1996
- Status
-
Private
- Employees
-
213
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
8
Simulations Plus General Information
Description
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Contact Information
Website
www.simulations-plus.comCorporate Office
- Research Triangle Park
- P.O. Box 12317
- Durham, NC 27709
- United States
Corporate Office
- Research Triangle Park
- P.O. Box 12317
- Durham, NC 27709
- United States
Simulations Plus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Simulations Plus Comparisons
Industry
Financing
Details
Simulations Plus Competitors (4)
One of Simulations Plus’s 4 competitors is Pacific BioSciences of California, a Formerly VC-backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pacific BioSciences of California | Formerly VC-backed | Menlo Park, CA | ||||
| Bionano Genomics | Formerly VC-backed | San Diego, CA | ||||
| Lonza Group | Corporation | Basel, Switzerland | ||||
| SeraCare | Formerly PE-Backed | Milford, MA |
Simulations Plus Patents
Simulations Plus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024173096-A1 | Simulation-based dynamic risk stratification | Inactive | 17-Feb-2023 | ||
| US-6625585-B1 | Method and system for artificial intelligence directed lead discovery though multi-domain agglomerative clustering | Inactive | 18-Feb-2000 | ||
| US-20040117164-A1 | Method and system for artificial intelligence directed lead discovery in high throughput screening data | Inactive | 19-Feb-1999 | ||
| US-6904423-B1 | Method and system for artificial intelligence directed lead discovery through multi-domain clustering | Inactive | 19-Feb-1999 | G06N5/02 |
Simulations Plus Signals
Simulations Plus Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Simulations Plus Investments & Acquisitions (8)
Simulations Plus’s most recent deal was a Later Stage VC with Nurocor for . The deal was made on 21-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nurocor | 21-May-2025 | Later Stage VC | Enterprise Systems (Healthcare) | ||
| Pro-ficiency | 11-Jun-2024 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Immunetrics | 16-Jun-2023 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Lixoft | 01-Apr-2020 | Merger/Acquisition | Business/Productivity Software | ||
| DILIsym Services | 01-Jun-2017 | Merger/Acquisition | Other Healthcare Technology Systems |
Simulations Plus FAQs
-
When was Simulations Plus founded?
Simulations Plus was founded in 1996.
-
Where is Simulations Plus headquartered?
Simulations Plus is headquartered in Durham, NC.
-
What is the size of Simulations Plus?
Simulations Plus has 213 total employees.
-
What industry is Simulations Plus in?
Simulations Plus’s primary industry is Other Healthcare Technology Systems.
-
Is Simulations Plus a private or public company?
Simulations Plus is a Private company.
-
What is the current valuation of Simulations Plus?
The current valuation of Simulations Plus is .
-
What is Simulations Plus’s current revenue?
The current revenue for Simulations Plus is .
-
How much funding has Simulations Plus raised over time?
Simulations Plus has raised $5.75M.
-
Who are Simulations Plus’s investors?
Altaris has invested in Simulations Plus.
-
Who are Simulations Plus’s competitors?
Pacific BioSciences of California, Bionano Genomics, Lonza Group, and SeraCare are competitors of Simulations Plus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process